About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
M
Using Cytoreductive Therapy to Prevent Cardiovascular Events in Patients With Polycythemia Vera
By
Monia Marchetti
333 views
April 18, 2023
0 Comments
Login to view comments.
Click here to Login
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
Featured Video
13:04
Winship Cancer Institute - Emory University
Treatment-Related Quality of Life in MF
Feat.
A. Hunter
Related Content
AUTOPLAY
ON
27:37
Indy Hematology Review
Review of Myeloproliferative Neoplasms
Feat.
A. Tefferi
06:00
2024 Clinical Case Studies
Clinical Case Review: A Not-So-Sweet Case of Vulvar Ulceration
Feat.
A. Geisler
10:04
University of Colorado Department of Medicine
Cardiotoxicity in Breast Cancer – Case Discussion
Feat.
L. Kondapalli
08:18
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Treatment Strategies for Hematocrit Control…
Feat.
A. Zhou
11:43
University of Colorado Department of Medicine
How to Minimize and Manage Checkpoint Inhibitors Adverse Cardiac Eve…
Feat.
L. Kondapalli
05:20
Prithviraj Bose
When to Switch From Hydroxyurea to Ruxolitinib in PV
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
21:52
Insights from 2023 ASH Annual Meeting
ASH 2023 Summary: "MF, ET, and PV - Highlights and Clinical Imp…
Feat.
D. Tremblay
10:02
Insights from 2023 ASH Annual Meeting
ASH 2023 Summary: "The Best of MPNs - Highlights & Key Take…
Feat.
R. Mesa
10:39
University of Colorado Department of Medicine
Cardio-Oncology: Definitions and Scope
Feat.
L. Kondapalli
09:27
ASH 2022 Conference Coverage
MAJIC-PV Trial: Ruxolitinib vs. Best Available Therapy for PV Intole…
Feat.
M. McMullin
17:21
Daniel Addison
Cardiovascular Considerations With (Contemporary) BTKi in the Treatm…
13:34
EULAR 2023 Insights
EULAR 2023 Insights: From Pathogenesis to Therapy in Sjögren's …
Feat.
H. Bootsma
05:38
GRACE
Epcoritamab in NHL - Incidence and Management of CRS
Feat.
T. Phillips
16:25
Northwestern Medicine Oncology and Hematology
Diagnosis and Goals of Therapy in PV
Feat.
B. Stein
09:46
Scripps MD Anderson Cancer Center
Ruxolitinib in Polycythemia Vera: Learnings From the RESPONSE Trial
Feat.
D. Hermel
08:44
Krisstina Gowin
Management of Aquagenic Pruritis in Polycythemia Vera
31:12
UChicago Medicine
Practice-Changing Abstracts in NHL and HL From ASH 2023
Feat.
S. Smith
24:44
Indy Hematology Review
State of the Art in 2024: Emerging Therapies in Hematologic Malignan…
Feat.
R. Birhiray
20:25
Andrew Hahn
ADT for Prostate Cancer and Cardiovascular Health Considerations
